side affects of tirzepatide Incidence mild and severe effects of in SURPASS 1-5 Side Effects of Tirzepatide: Complete

Morgan Wealth ManagementNew YorkNew York - NYC (High Net Worth)$2M$977M$1-2.8M$1-10MEmmeline SwansonMerrill Wealth ManagementNew YorkNew York - NYC (High Net Worth)$250K$39.6B$10-500M$5-200MProfile SpotlightMichael KnuffWells Fargo AdvisorsNew YorkNew York - NYC (High Net Worth)$1M$1.7B$1-300M$1-300MLauren De SimoneMorgan Stanley Wealth ManagementNew YorkNew York - NYC (High Net Worth)$1M$567M$5-15M$2-10MRocco PapandreaMerrill Wealth ManagementNew YorkNew York - NYC (High Net Worth)$1M$1.7B$8.2-12.1M$8.6-37.8MProfile SpotlightStephanie AcklerAKD Wealth Partners | Wells Fargo Advisors Financial NetworkNew YorkNew York - NYC (High Net Worth)$2M$1.1B$3.3-12M$1-10MCharles NattMorgan Stanley Wealth ManagementNew YorkNew York - NYC (High Net Worth)$3M$2B$6-25M$4-15MPeter weissMorgan Stanley Wealth ManagementNew YorkNew York - NYC (High Net Worth)$250K$610M$750K-7M$300K-5MDaniel ShermanMorgan Stanley Wealth ManagementNew YorkNew York - NYC (High Net Worth)$1M$1.4B$2.5-15M$3-10MCharles AlbaneseMorgan Stanley Wealth ManagementNew YorkNew York - NYC (High Net Worth)$500K$1.9B$1-15M$1-10MJoseph LongobardiMorgan Stanley Wealth ManagementNew YorkNew York - NYC (High Net Worth)$1M$1.4B$5-10M$3-15MWill McKeeMorgan Stanley Wealth ManagementNew YorkNew York - NYC (High Net Worth)$500K$1.7B$4-50M$2.5-20MCasey EnnisMorgan Stanley Wealth ManagementNew YorkNew York - NYC (High Net Worth)$500K$415M$1-55M$1-55MBarbara RobertsMerrill Wealth ManagementNew YorkNew York - NYC (High Net Worth)$100K$905M$3-8M$1-30MSally CaiMerrill Wealth ManagementNew YorkNew York - NYC (High Net Worth)$1M$3B$3-15M$1-5MProfile SpotlightThomas PescherineJ.P

TABLE 1 Possible benefits and drawbacks of surgical and pharmacological interventions

Semaglutide is in the GLP-1 receptor agonist class of medications

For example, GIP stimulates insulin secretion but also increases GCG levels 7,8 , while the latter has a parallel role in elevating energy expenditure and blood glucose 9

Increasingly, these patients are asking me about peptides, specifically one called BPC-157

Moreover, a large-scale randomized controlled trial (RCTs) involving more than 17,000 individuals with obesity and cardiovascular disease demonstrated that semaglutide reduced the risk of cardiovascular death, myocardial infarction (MI), and stroke compared to the placebo 9